TELA Bio, Inc.TELANASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+21.7%
5Y CAGR+30.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+21.7%/yr
vs +28.1%/yr prior
5Y CAGR
+30.0%/yr
Recent deceleration
Acceleration
-6.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$25.93M+13.7%
2024$22.81M+24.4%
2023$18.34M+27.6%
2022$14.37M+35.0%
2021$10.65M+52.6%
2020$6.98M+13.0%
2019$6.17M+15.8%
2018$5.33M+211.3%
2017$1.71M-